Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-11-10
1988-07-05
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514381, 548253, 548341, A61K 3141, A61K 31415, C07D22314, C07D25704
Patent
active
047555181
ABSTRACT:
Novel benzoic acid or benzoic acid ester derivatives, pharmaceutical compositions and methods of use thereof are the present invention. Utility is for the treatment of arthritis, asthma, Raynaud's disease, inflammatory bowel disorders, trigeminal or herpetic neuralgia, inflammatory eye disorders, psoriasis, dental pain, and headaches, particularly vascular headaches, such as migraine, cluster, mixed vascular syndromes, as well as nonvascular, tension headaches.
REFERENCES:
patent: 3514383 (1970-05-01), Beal et al.
patent: 3953499 (1976-04-01), Pike et al.
Baer, "Tetrahedron Letters", No. 51, pp. 4697-4700 (1976).
Fujisawa et al., "Chemistry Letters, Chem. Soc. Japan", pp. 71-74 (1982).
Leblanc et al., J. Org. Chem, 51, pp. 789-793 (1986).
Johnson Graham
Rafferty Michael F.
Hollrah Glennon H.
Springer D. B.
Thierstein Joan
Warner-Lambert & Company
LandOfFree
Imidazolyl or tetrazolyl substituted benzoic acid derivatives an does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazolyl or tetrazolyl substituted benzoic acid derivatives an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazolyl or tetrazolyl substituted benzoic acid derivatives an will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2332597